Press Releases 2023

Biocon Biologics  /  Press Releases  /  Press Releases 2023

Biocon Biologics Partners with Sandoz for the Distribution of “Adalimumab BS Subcutaneous Injection [FKB]” in Japan

  • Posted by: Biocon Biologics

Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries

  • Posted by: Biocon Biologics

Biocon Biologics Recognized as an Asia IP Elite for 2023, IPR Team adjudged as the Team of the Year

  • Posted by: Biocon Biologics

Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe

  • Posted by: Biocon Biologics

Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%

  • Posted by: Biocon Biologics

EdelGive and Hurun India recognizes Kiran Mazumdar-Shaw as the Second most generous women philanthropist in India

  • Posted by: Biocon Biologics

Biocon Biologics Announces Divestment of Two Non-Core Branded Formulations – India Business Units

  • Posted by: Biocon Biologics

Biocon Ranked No. 8 Among Science Magazine’s Best Employers in Global Biotech and Pharma Sector

  • Posted by: Biocon Biologics

Kedar Upadhye Appointed as New CFO of Biocon Biologics Current CFO MB Chinappa to take on a Strategic Finance role at Biocon Group

  • Posted by: Biocon Biologics

Biocon Board Appoints Peter Bains as Group CEO

  • Posted by: Biocon Biologics
Share